196 related articles for article (PubMed ID: 24076992)
1. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
[TBL] [Abstract][Full Text] [Related]
2. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
3. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
Scholes D; Stergachis A; Heidrich FE; Andrilla H; Holmes KK; Stamm WE
N Engl J Med; 1996 May; 334(21):1362-6. PubMed ID: 8614421
[TBL] [Abstract][Full Text] [Related]
4. [Chlamydia trachomatis infection in women and the use of oral contraceptives].
van Voorst Vader PC; Lier JG; Posma AL; Schröder FP; Schirm J; Kauer FM
Ned Tijdschr Geneeskd; 1991 Feb; 135(8):323-7. PubMed ID: 2008220
[TBL] [Abstract][Full Text] [Related]
5. Association between enhanced screening for Chlamydia trachomatis and Neisseria gonorrhoeae and reductions in sequelae among women.
Anschuetz GL; Asbel L; Spain CV; Salmon M; Lewis F; Newbern EC; Goldberg M; Johnson CC
J Adolesc Health; 2012 Jul; 51(1):80-5. PubMed ID: 22727081
[TBL] [Abstract][Full Text] [Related]
6. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses.
Owusu-Edusei K; Bohm MK; Chesson HW; Kent CK
Am J Prev Med; 2010 Jun; 38(6):652-7. PubMed ID: 20494242
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA; Van Bergen JE; Morré SA; Postma MJ
Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
[TBL] [Abstract][Full Text] [Related]
9. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
10. Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study.
Qvigstad E; Skaug K; Jerve F; Fylling P; Ulstrup JC
Br J Vener Dis; 1983 Jun; 59(3):189-92. PubMed ID: 6850266
[TBL] [Abstract][Full Text] [Related]
11. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
[TBL] [Abstract][Full Text] [Related]
12. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
[TBL] [Abstract][Full Text] [Related]
13. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies.
Herzog SA; Heijne JC; Althaus CL; Low N
Sex Transm Dis; 2012 Aug; 39(8):628-37. PubMed ID: 22801346
[TBL] [Abstract][Full Text] [Related]
14. Screening for chlamydial infections in women with pelvic inflammatory diseases.
Chowdhary A; Malhotra VL; Deb M; Rai U
J Commun Dis; 1998 Sep; 30(3):163-6. PubMed ID: 10093422
[TBL] [Abstract][Full Text] [Related]
15. Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study.
Herzog SA; Althaus CL; Heijne JC; Oakeshott P; Kerry S; Hay P; Low N
BMC Infect Dis; 2012 Aug; 12():187. PubMed ID: 22883325
[TBL] [Abstract][Full Text] [Related]
16. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis in pelvic inflammatory disease.
Shrikhande SN; Joshi SG; Zodpey SP; Saoji AM
Indian J Pathol Microbiol; 1995 Apr; 38(2):181-4. PubMed ID: 8919106
[TBL] [Abstract][Full Text] [Related]
18. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
19. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
[TBL] [Abstract][Full Text] [Related]
20. Risk of sequelae after Chlamydia trachomatis genital infection in women.
Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
